[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

New GlobalData's Studies on Pharmaceuticals Industry

13 Feb 2012 • by Natalie Aster

Gallbladder Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2018. Gallbladder cancer therapeutics market to be worth $156.0m in 2010. It is forecast to decline at a Compound Annual Growth Rate (CAGR) of 2.0% for the next eight years to reach $148.68m by 2018. The decline in the gallbladder cancer therapeutics market is primarily due to the patent expiries of Gemzar and Xeloda, which are expected to leave the market vulnerable to generics.

The current products for gallbladder cancer have significant side effect concerns such as alopecia, lethargy, thrombocytopenia and neutropenia. However, many patients are left with no choice other than the current products, which can provide some degree of disease alleviation. Developing new molecular targeted agents should lead to future blockbusters with the potential to capture major market shares. Consequently, there is a huge need for novel drugs to enter the market with benefits over the well-established existing products.

Vitiligo Therapeutics - Pipeline Assessment and Market Forecasts to 2019. Global vitiligo therapeutics market to be worth $1.4 billion in 2011. It is expected to grow to $2.7 billion by 2019 at a Compound Annual Growth Rate (CAGR) of 8.8%. This growth can be primarily attributed to the rise in the number of patients undergoing treatment for vitiligo and the launch of Scenesse (afamelanotide) in 2014. The vitiligo therapeutics market will witness only one new drug approval in the forecast period. The new introduction in the market will be positioned as a novel therapy among moderately efficacious generics and is expected to be launched at a premium price, thus limiting its market penetration in initial years. The market will be characterized with the dominance of generic products as only one new product is scheduled to be launched in the forecast period.

To conclude, the vitiligo therapeutics market will continue to be dominated by generics during the forecast period.

Price Per Report: $ 3.995,00 (Single User License)

More new market research reports by can be found at GlobalDatas page.

To order the report or ask for sample pages contact [email protected]


MarketPublishers, Ltd.
Tanya Rezler
Tel: +44 208 144 6009
Fax: +44 207 900 3970
[email protected]

Analytics & News

Weekly Digest